UroGen Pharma (URGN) Amortizatization of Intangibles (2019 - 2025)
Historic Amortizatization of Intangibles for UroGen Pharma (URGN) over the last 7 years, with Q3 2025 value amounting to $160000.0.
- UroGen Pharma's Amortizatization of Intangibles fell 9302.22% to $160000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year increase of 9502.49%. This contributed to the annual value of $2.9 million for FY2024, which is 17959.38% up from last year.
- Latest data reveals that UroGen Pharma reported Amortizatization of Intangibles of $160000.0 as of Q3 2025, which was down 9302.22% from $866000.0 recorded in Q2 2025.
- In the past 5 years, UroGen Pharma's Amortizatization of Intangibles ranged from a high of $2.3 million in Q3 2024 and a low of -$961000.0 during Q1 2024
- Over the past 5 years, UroGen Pharma's median Amortizatization of Intangibles value was $238000.0 (recorded in 2021), while the average stood at $443210.5.
- Over the last 5 years, UroGen Pharma's Amortizatization of Intangibles had its largest YoY gain of 242075.47% in 2024, and its largest YoY loss of 33787.13% in 2024.
- Over the past 5 years, UroGen Pharma's Amortizatization of Intangibles (Quarter) stood at $238000.0 in 2021, then soared by 184.45% to $677000.0 in 2022, then crashed by 92.17% to $53000.0 in 2023, then surged by 2420.75% to $1.3 million in 2024, then tumbled by 88.02% to $160000.0 in 2025.
- Its last three reported values are $160000.0 in Q3 2025, $866000.0 for Q2 2025, and $774000.0 during Q1 2025.